Mitchell Mcleod Pugh & Williams Inc Bristol Myers Squibb CO Transaction History
Mitchell Mcleod Pugh & Williams Inc
- $436 Million
- Q2 2024
A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 11,367 shares of BMY stock, worth $601,314. This represents 0.11% of its overall portfolio holdings.
Number of Shares
11,367
Previous 19,042
40.31%
Holding current value
$601,314
Previous $1.03 Million
54.26%
% of portfolio
0.11%
Previous 0.25%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,402Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.87 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.39 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.84 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.95 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.12 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $112B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...